Evidence map›Paper›PMID 40255577›Full record

ArticleFrontiers in pharmacology2025

Case Report: A case of Felty's syndrome with initial presentation of pleural effusion and subsequent

Haifeng Yang, Weiqin Wang, Yongfeng Liu, Yibo Yang, Yiliang Su

Abstract readCase Reports
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haifeng YangDepartment of Pulmonay and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Weiqin WangDepartment of Pulmonay and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yongfeng LiuDepartment of Pulmonay and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yibo YangSchool of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, China.
Yiliang SuDepartment of Pulmonay and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pleural effusion is a common disease in respiratory medicine, and rheumatoid arthritis (RA) is one of the causes of pleural effusion. Felty's syndrome is a special manifestation of RA. We report a case of Felty's syndrome with pleural effusion as the initial symptom and the subsequent diagnosis and treatment of the patient's secondary pyothorax. Case presentation: We report the case of a 78-year-old male who was admitted to the hospital after more than 1 year of discovered pleural effusion. After consultation with the Department of Rheumatology and Immunology, and considering the patient's symptoms of joint deformity and swelling pain, combined with decreased white blood cells, decreased platelets, and splenomegaly, the patient was diagnosed with RA Felty's syndrome. The patient was treated with iguratimod and methylprednisolone. Three months later, the patient was diagnosed as Conclusion: Felty's syndrome is a rare manifestation of RA. Pleural effusion may be the initial manifestation of RA, and secondary infections are prone to occur during the treatment of RA and Felty's syndrome. The combination of sensitive antibiotics and medical thoracoscopy can effectively treat secondary pyothorax.

Indexed as

Escherichia coliFelty’s syndromemedical thoracoscopypleural effusionpyothoraxRheumatoid arthritis

Identifiers

PMID40255577
PMCPMC12006163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.